Patents Examined by Natasha Patel
  • Patent number: 11969598
    Abstract: Systems and methods for controlling blood pressure via electrical stimulation of the heart are disclosed. Embodiments may include at least two different stimulation patterns, each configured to reduce blood pressure to a different degree, and may alternate between stimulation patterns based on the need of a patient, for example, alternating between day and night or between periods of strenuous and light activity. Some embodiments may take advantage of a slow baroreflex response that occurs after treatment is stopped, suspending treatment for extended periods, and then resuming treatment before blood pressure levels reach pretreatment values. Embodiments may control blood pressure by controlling atrial pressure and atrial stretch.
    Type: Grant
    Filed: August 9, 2022
    Date of Patent: April 30, 2024
    Assignee: BackBeat Medical, LLC
    Inventors: Yuval Mika, Darren Sherman, Robert S. Schwartz, Robert A. Van Tassel, Daniel Burkhoff
  • Patent number: 11951313
    Abstract: Devices, systems, and methods deliver implantable medical devices for ventricular-from-atrial (VfA) cardiac therapy. A VfA device may be implanted in the right atrium (RA) with an electrode extending from the right atrium into the left ventricular myocardium. A flexible leed, or another probe, may be advanced to the potential implantation site and used to identify a precise location for implantation of a medical device, such as an electrode, leadlet, lead, or intracardiac device. Some methods may include locating a potential implantation site in the triangle of Koch region in the right atrium of a patient's heart; attaching a fixation sheath to the right-atrial endocardium in the potential implantation site; and implanting the medical device over a guide wire at the potential implantation site. An implantable medical device may include an intracardiac housing and a leadlet, which may be delivered by these methods.
    Type: Grant
    Filed: November 14, 2019
    Date of Patent: April 9, 2024
    Assignee: Medtronic, Inc.
    Inventors: Matthew D. Bonner, Andrea J. Asleson, Jean M. Carver, Kathryn Hilpisch
  • Patent number: 11948688
    Abstract: The exemplified methods and systems provide a phase space volumetric object in which the dynamics of a complex, quasi-periodic system, such as the electrical conduction patterns of the heart, or other biophysical-acquired signals of other organs, are represented as an image of a three dimensional volume having both a volumetric structure (e.g., a three dimensional structure) and a color map to which features can be extracted that are indicative the presence and/or absence of pathologies, e.g., ischemia relating to significant coronary arterial disease (CAD). In some embodiments, the phase space volumetric object can be assessed to extract topographic and geometric parameters that are used in models that determine indications of presence or non-presence of significant coronary artery disease.
    Type: Grant
    Filed: September 10, 2021
    Date of Patent: April 2, 2024
    Assignee: Analytics for Life Inc.
    Inventors: Sunny Gupta, Timothy William Fawcett Burton, Shyamlal Ramchandani
  • Patent number: 11944815
    Abstract: Devices, systems and methods are disclosed that allow a patient to self-treat a medical condition, such as headache, by noninvasive stimulation of a nerve. A system comprises a stimulator having an interface configured to contact an outer skin surface of a patient and an energy source coupled to the interface. The energy source transmits an electrical impulse through the interface transcutaneously through the outer skin surface of the patient to a nerve of the patient such that the nerve is modulated. The system further comprises a mobile device coupled to the stimulator to transmit data to the stimulator. The data includes a therapy regimen to reduce one or more symptoms of a headache in the patient.
    Type: Grant
    Filed: November 9, 2021
    Date of Patent: April 2, 2024
    Assignee: ELECTROCORE, INC.
    Inventors: Bruce J. Simon, Joseph P. Errico, John T. Raffle
  • Patent number: 11872397
    Abstract: Transcranial electrostimulation systems and methods are contemplated in which a high current level, charge balanced alternating current electrical signal is generated for delivery to the occipital region of a patient's brain. By stimulating the brain with a charged balanced stimulation current with a stimulation current envelope defining one or more series of pulses at particular frequencies and durations designed to evoke metabolic response in the neurons, significant improvements in efficacy and reductions in patient discomfort may be achieved relative to earlier methods of transcranial electrical stimulation, especially those in which result in a resultant rectified direct current component being administered to the patient.
    Type: Grant
    Filed: December 9, 2020
    Date of Patent: January 16, 2024
    Assignee: NEXALIN TECHNOLOGY, INC.
    Inventor: John Patrick Claude
  • Patent number: 11850420
    Abstract: The present invention discloses a brain stimulation systems, devices and methods to: induce lucid reality; improve sleep; improve motor performance; improve learning; enhance gaming activities; improve mental health; and any combination thereof. The system comprises at least one head mounted device; at least one power supply unit; at least one communication unit; at least one microcontroller; at least one external device; and at least one cloud-based storing device.
    Type: Grant
    Filed: September 18, 2017
    Date of Patent: December 26, 2023
    Assignee: NYX Technologies Ltd.
    Inventors: Tomer Aharonovitch, Ophir Orenstein
  • Patent number: 11844736
    Abstract: An apparatus, system, and method for the regeneration of tissue by pre-tensioning of tissue prior to or in conjunction with the application of mechanotransduction therapy.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: December 19, 2023
    Assignee: Pelvital USA, Inc.
    Inventors: Gunnar Leivseth, Ole Jakob Olsen, Dale Wahlstrom, Luke Dery
  • Patent number: 11844944
    Abstract: A method for assessment, optimization and logging of the effects of a therapy for a medical condition, including (a) receiving into a signal processor input signals indicative of the subject's brain activity; (b) characterizing the spatio-temporal behavior of the brain activity using the signals; (c) delivering a therapy to a target tissue of the subject; (d) characterizing the spatio-temporal effect of the therapy on the brain activity; (e) in response to the characterizing, optimizing at least one parameter of the therapy if the brain activity has not been satisfactorily modified and/or has been adversely modified by the therapy; (f) characterizing the spatio-temporal effect of the at least one optimized parameter; and (g) logging to memory the at least one optimized parameter. A computer readable program storage unit encoded with instructions that, when executed by a computer, performs the method.
    Type: Grant
    Filed: May 3, 2021
    Date of Patent: December 19, 2023
    Assignee: Flint Hills Scientfic, LLC.
    Inventor: Ivan Osorio
  • Patent number: 11839767
    Abstract: Neuromodulation of cranial nerves can be used to treat sleep or breathing disorders, among other diseases and disorders. A neuromodulation system can include a housing configured for implantation in an anterior cervical region of a patient, such as at or under a mandible of the patient, such as at least partially in one or more of a submental triangle, a submandibular triangle, and a carotid triangle. The system can include an electrode lead coupled to the housing, and the electrode lead can include an electrode configured to be disposed at or near a cranial nerve target in the patient. The system can be configured to generate electrical neuromodulation signals for delivery to the cranial nerve target using the electrode.
    Type: Grant
    Filed: January 8, 2021
    Date of Patent: December 12, 2023
    Assignee: NuXcel2, L.L.C.
    Inventors: Lynn Elliott, Stephen C. Masson, Jr.
  • Patent number: 11839764
    Abstract: Systems and methods are disclosed that allow a patient to self-treat a medical condition, such as migraine headache and trigeminal neuralgia and the like, by noninvasive electrical stimulation of nerves of the head, particularly supraorbital, supratrochlear, infraorbital, and mental nerves in the vicinity of their foramen or notch. The system comprises a stimulator having one or more electrodes that apply electrical impulses transcutaneously through the patient's skin to the targeted nerve. The stimulator may be coupled to a handheld mobile device, such as a smartphone, for receiving a treatment regimen to treat the medical condition. The system is designed to address problems that arise particularly during self-treatment, when a medical professional is not present.
    Type: Grant
    Filed: June 13, 2021
    Date of Patent: December 12, 2023
    Assignee: ElectroCore, Inc.
    Inventors: Joseph P. Errico, Steven Mendez, Bruce J. Simon
  • Patent number: 11819690
    Abstract: A hearing device is provided. The hearing device comprises a first portion configured to be arranged at a head of a user and to provide a signal to a second portion.
    Type: Grant
    Filed: June 21, 2022
    Date of Patent: November 21, 2023
    Assignee: Cochlear Limited
    Inventors: Werner Meskens, Tadeusz Jurkiewicz, Steve Winnal, Limin Zhong
  • Patent number: 11819682
    Abstract: Devices and methods of use for introduction and implantation of an electrode as part of a minimally invasive technique. An implantable baroreflex activation system includes a control system having an implantable housing, an electrical lead, attachable to the control system, and an electrode structure. The electrode structure is near one end of the electrical lead, and includes a monopolar electrode, a backing material having an effective surface area larger than the electrode, and a releasable pivotable interface to mate with an implant tool. The electrode is configured for implantation on an outer surface of a blood vessel and the control system is programmed to deliver a baroreflex therapy via the monopolar electrode to a baroreceptor within a wall of the blood vessel.
    Type: Grant
    Filed: June 11, 2021
    Date of Patent: November 21, 2023
    Assignee: CVRx, Inc.
    Inventors: Adam Cates, Eric Lovett, Loren Murney, Kip Ludwig, Paul Pignato, Brian Soltis
  • Patent number: 11806541
    Abstract: Systems and methods involve an intrathoracic cardiac stimulation device operable to provide autonomous cardiac sensing and energy delivery. The cardiac stimulation device includes a housing configured for intrathoracic placement relative to a patient's heart. A fixation arrangement of the housing is configured to affix the housing at an implant location within cardiac tissue or cardiac vasculature. An electrode arrangement supported by the housing is configured to sense cardiac activity and deliver stimulation energy to the cardiac tissue or cardiac vasculature. Energy delivery circuitry in the housing is coupled to the electrode arrangement. Detection circuitry is provided in the housing and coupled to the electrode arrangement. Communications circuitry may optionally be supported by the housing. A controller in the housing coordinates delivery of energy to the cardiac tissue or cardiac vasculature in accordance with an energy delivery protocol appropriate for the implant location.
    Type: Grant
    Filed: February 17, 2021
    Date of Patent: November 7, 2023
    Assignee: CARDIAC PACEMAKERS, INC.
    Inventors: Jeffrey P. Bodner, Randy Bierwerth
  • Patent number: 11806118
    Abstract: Systems and methods are provided for operating a physiological monitoring system that comprises a distributed algorithm. The physiological monitoring system may comprise a sensor and a physiological monitor that may be communicatively coupled with the sensor. The sensor may store algorithm configuration data; and the physiological monitor may store an executable code segment configured to execute a first algorithm. The physiological monitor may be configured to receive the algorithm configuration data and to configure or modify at least part of the first algorithm based upon the algorithm configuration data to determine at least one physiological parameter of a subject based on physiological signal provided by the sensor.
    Type: Grant
    Filed: January 6, 2021
    Date of Patent: November 7, 2023
    Assignee: COVIDIEN LP
    Inventor: Daniel Lisogurski
  • Patent number: 11801379
    Abstract: Connectors and related methods for fluidly coupling a blood pump with an aorta facilitate implantation of the blood pump. A method of fluidly coupling a blood pump with an aorta includes positioning a connector device defining a passageway extending between a proximal opening and a distal opening. The connector device includes a support member surrounding the distal opening. The support member is interfaced with a wall of the aorta so that the distal opening is at a desired location of an inlet opening in the aorta. The support member is attached to the aorta around the distal opening so as to form a fluid seal and stabilize the connector device. A slit is incised in the wall of the aorta to form the inlet opening in the aorta. A proximal opening of the tubular connector is fluidly coupled with an outflow graft tube of the blood pump.
    Type: Grant
    Filed: April 29, 2021
    Date of Patent: October 31, 2023
    Assignee: TC1 LLC
    Inventor: Sarah Cohen
  • Patent number: 11801384
    Abstract: Method for calibrating a nerve stimulation device comprising (a) providing the user with an initial stimulus at a sub-sensory level and obtaining feedback regarding whether the stimulus is felt; (b) if it is not felt, increasing the stimulation level by a first level variation and again obtaining feedback; (c) repeating the previous step until feeling the stimulus is reported; (d) reducing stimulus by the initial level variation; (e) repeating the process from the previously established level while using a second level variation is used which is smaller than the first level variation; (f) once stimulus feeling is reported, the level is again reduced by the second level variation; (g) this level, achieved after the second “crossing” of the threshold, can be used as the sensory threshold value; (h) additional calibration rounds can be conducted using ever-lower level variations for each subsequent round to more accurately the sensory threshold is determined.
    Type: Grant
    Filed: October 11, 2021
    Date of Patent: October 31, 2023
    Assignee: NEUVANA, LLC
    Inventors: Ami Brannon, Kermit Falk, Vincent Manopoli
  • Patent number: 11793409
    Abstract: The invention relates to a system for the early detection of invalidating states of persons, such as a postoperative bleeding of a patient for example, in particular secondary bleeding after organ surgery, comprising a detector unit (30) for continuously detecting multiple selected parameters. The detector unit has sensors (14, 16, 18), a computing unit, an interface and an analysis logic which evaluates the probability of the presence of a health anomaly, such as the probability of postoperative bleeding for example, on the basis of the present parameter states. Additionally, a display device (40) is provided by means of which the evaluation is displayed. The pressure in the postoperative organ compartment and/or a parameter which represents the expansion of the section of the skin adjoining the organ compartment is selected as the selected parameter.
    Type: Grant
    Filed: September 15, 2017
    Date of Patent: October 24, 2023
    Assignee: ISAR-M GmbH
    Inventor: Anne Schardey
  • Patent number: 11794028
    Abstract: In one example in accordance with the present disclosure a method is described. According to the method, an emitter of a transcranial electromagnetic treatment (TEMT) system is positioned at a location relative to a head of a patient such that the emitter emits an electromagnetic frequency signal toward the head of the patient. The emitter is activated to apply TEMT to the patient to treat amyloid oligomers. In some examples, the TEMT has a frequency between 1 MHz and 430 THz.
    Type: Grant
    Filed: July 22, 2020
    Date of Patent: October 24, 2023
    Assignee: NeuroEM Therapeutics, Inc.
    Inventors: Gary W. Arendash, Robert Baranowski
  • Patent number: 11794006
    Abstract: The present invention discloses a brain stimulation systems, devices and methods to: induce lucid reality; improve sleep; improve motor performance; improve learning; enhance gaming activities; improve mental health; and any combination thereof. The system comprises at least one head mounted device; at least one power supply unit; at least one communication unit; at least one microcontroller; at least one external device; and at least one cloud-based storing device.
    Type: Grant
    Filed: September 18, 2017
    Date of Patent: October 24, 2023
    Assignee: NYX Technologies Ltd.
    Inventors: Tomer Aharonovitch, Ophir Orenstein
  • Patent number: 11793445
    Abstract: Methods and systems are provided for detecting arrhythmias in cardiac activity. The methods and systems declare a current beat, from the CA signals, to be a candidate beat or an ineligible beat based on whether the current beat satisfies the rate based selection criteria. The determining and declaring operations are repeated for multiple beats to form an ensemble of candidate beats. The method and system calculate a P-wave segment ensemble from the ensemble of candidate beats, perform a morphology-based comparison between the P-wave segment ensemble and at least one of a monophasic or biphasic template, declare a valid P-wave to be present within the CA signals based on the morphology-based comparison, and utilize the valid P-wave in an arrhythmia detection process to determine at least one of an arrhythmia entry, arrhythmia presence or arrhythmia exit.
    Type: Grant
    Filed: November 2, 2020
    Date of Patent: October 24, 2023
    Assignee: Pacesetter, Inc.
    Inventors: Neha Malhotra, Fujian Qu, Jong Gill, Stuart Rosenberg, Gene A. Bornzin, Fady Dawoud